Dr. Jinesh P. Mehta, MD

Dr. Mehta practices at Cleveland Clinic Florida - Weston in Weston, Florida.

Dr. Mehta's NPI, 1619918232, was assigned on June 8, 2006. Dr. Mehta graduated from Seth G.S. Medical College in 1999. Dr. Mehta holds Florida license ME110584.

Dr. Mehta's primary practice is Cleveland Clinic Florida - Weston, at 2950 Cleveland Clinic Blvd, Weston, FL 33331 in Broward County. The practice phone is (954) 689-5000.

Dr. Mehta's primary practice is Cleveland Clinic Florida - Weston in Weston, Florida. Dr. Mehta is also affiliated with Cleveland Clinic Weston Hospital. The medical group on file is Cleveland Clinic Florida. Dmand AI also links Dr. Mehta to 2 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mehta practices, 3 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Mehta's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Mehta is board certified in critical care medicine by the American Board of Internal Medicine. Dmand AI has Dr. Mehta's licenses on file in 2 states: Florida and Kentucky.

Dmand AI lists asthma, bronchitis, chronic lung disease, chronic obstructive pulmonary disease (COPD), chronic respiratory failure, pulmonary fibrosis, pulmonary heart disease and sleep apnea among the conditions Dr. Mehta treats.

CMS data shows 1,915 Medicare services from Dr. Mehta across 14 procedure codes in 2024, for 604 Medicare patients. Medicare paid $96,336 for them.

CMS counts 604 Medicare patients who saw Dr. Mehta in 2024. The largest group is 65 to 74, with 239 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 2.35, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mehta's median patient age at 69, with 55% women.

In 2024, Dr. Mehta wrote 3,239 Medicare Part D claims for 531 patients. 44% of them were for generic drugs. CMS names the drug for 2,934 of them, across 49 drugs with 11 or more claims each, at $9,950,499 in total drug cost. In 2023, CMS named 2,224 claims across 44 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Mehta for performance year 2024, reported through an alternative payment model (APM). Dr. Mehta accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Mehta as offering telehealth.

Dmand AI links 17 papers to Dr. Mehta, published from 2008 to 2020. 2020 was the busiest year, with 4. Dr. Mehta has published most often in Cureus. Dr. Mehta's most frequent co-authors are Franck F. Rahaghi, MD, James Benjamin Gleason, MD and Edward B. Savage, MD.

Dmand AI links Dr. Mehta to 7 clinical trials, 3 of them phase 3 studies. Conditions studied include Pulmonary Arterial Hypertension, Hypertension, Pulmonary and Cryptogenic Organizing Pneumonia. United Therapeutics sponsors the most, 3.

CMS Open Payments shows 244 general payments to Dr. Mehta from 21 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 73% of the total. United Therapeutics Corporation paid the most, $70,930.

Dmand AI lists 1 award for Dr. Mehta, most recently CMS Stage 1 EHR in 2013.

Dr. Mehta graduated from Seth G.S. Medical College in 1999. Dr. Mehta is a member of ACCP and ATS.

Dr. Mehta is in network with 14 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.